• Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +4
  • Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

    Not recruiting

    3 1 1
    Belgium Germany The Netherlands Spain Sweden
  • Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

    Not recruiting

    4 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Finland France +5
  • Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Germany Ireland Italy Lithuania +2
  • Study on the Effectiveness of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Treatment Failure

    Not recruiting

    2 1 1 1
    France Germany
  • Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

    Not recruiting

    2 1 1 1
    Belgium Ireland Spain
  • Study on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium The Netherlands
  • Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1
    Investigated drugs:
    Austria Czechia Denmark France Germany Greece +6
  • Study on the Effects of Atacicept in Adults with IgA Nephropathy

    Not recruiting

    4 1 1
    Belgium Croatia Czechia Denmark Estonia France +7
  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Estonia France Greece Italy Norway +3

powered by